These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 33423649)

  • 1. Cardiac MRI in Autoimmune Diseases: Where Are We Now?
    Vallianou NG; Geladari E; Panagopoulos F; Kalantzi M
    Curr Cardiol Rev; 2021; 17(5):e160721190002. PubMed ID: 33423649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence and prognostic significance of myocardial late gadolinium enhancement in patients with sarcoidosis without cardiac manifestation.
    Nagai T; Kohsaka S; Okuda S; Anzai T; Asano K; Fukuda K
    Chest; 2014 Oct; 146(4):1064-1072. PubMed ID: 24853830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Value of Late Gadolinium Enhancement CMR in Systemic Amyloidosis.
    Raina S; Lensing SY; Nairooz RS; Pothineni NV; Hakeem A; Bhatti S; Pandey T
    JACC Cardiovasc Imaging; 2016 Nov; 9(11):1267-1277. PubMed ID: 27568115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy.
    Wu KC; Weiss RG; Thiemann DR; Kitagawa K; Schmidt A; Dalal D; Lai S; Bluemke DA; Gerstenblith G; Marbán E; Tomaselli GF; Lima JA
    J Am Coll Cardiol; 2008 Jun; 51(25):2414-21. PubMed ID: 18565399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of cardiovascular magnetic resonance in patients with biopsy-proven systemic sarcoidosis.
    Flamée L; Symons R; Degtiarova G; Dresselaers T; Gheysens O; Wuyts W; Van Cleemput J; Bogaert J
    Eur Radiol; 2020 Jul; 30(7):3702-3710. PubMed ID: 32166494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Value of Myocardial Scarring on CMR in Patients With Cardiac Sarcoidosis.
    Coleman GC; Shaw PW; Balfour PC; Gonzalez JA; Kramer CM; Patel AR; Salerno M
    JACC Cardiovasc Imaging; 2017 Apr; 10(4):411-420. PubMed ID: 27450877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular magnetic resonance evaluation of paediatric patients with systemic lupus erythematosus and cardiac symptoms.
    Mavrogeni S; Smerla R; Grigoriadou G; Servos G; Koutsogeorgopoulou L; Karabela G; Stavropoulos E; Spiliotis G; Kolovou G; Papadopoulos G
    Lupus; 2016 Mar; 25(3):289-95. PubMed ID: 26453663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Characteristics of Late Gadolinium Enhancement in Patients with Cardiac Sarcoidosis.
    Matsumoto K; Ehara S; Sakaguchi M; Otsuka K; Hasegawa T; Shimada K; Yoshiyama M
    Osaka City Med J; 2015 Jun; 61(1):9-17. PubMed ID: 26434101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presence of Late Gadolinium Enhancement by Cardiac Magnetic Resonance Among Patients With Suspected Cardiac Sarcoidosis Is Associated With Adverse Cardiovascular Prognosis: A Systematic Review and Meta-Analysis.
    Hulten E; Agarwal V; Cahill M; Cole G; Vita T; Parrish S; Bittencourt MS; Murthy VL; Kwong R; Di Carli MF; Blankstein R
    Circ Cardiovasc Imaging; 2016 Sep; 9(9):e005001. PubMed ID: 27621357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ferumoxytol-enhanced cardiovascular magnetic resonance detection of early stage acute myocarditis.
    Tada Y; Tachibana A; Heidary S; Yang PC; McConnell MV; Dash R
    J Cardiovasc Magn Reson; 2019 Dec; 21(1):77. PubMed ID: 31842900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complementary Role of CMR to Conventional Screening in the Diagnosis and Prognosis of Cardiac Sarcoidosis.
    Kouranos V; Tzelepis GE; Rapti A; Mavrogeni S; Aggeli K; Douskou M; Prasad S; Koulouris N; Sfikakis P; Wells A; Gialafos E
    JACC Cardiovasc Imaging; 2017 Dec; 10(12):1437-1447. PubMed ID: 28330653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Utility of Cardiac Magnetic Resonance Imaging in the Diagnosis of Cardiac Sarcoidosis.
    Stanton KM; Ganigara M; Corte P; Celermajer DS; McGuire MA; Torzillo PJ; Corte TJ; Puranik R
    Heart Lung Circ; 2017 Nov; 26(11):1191-1199. PubMed ID: 28501519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics and clinical relevance of late gadolinium enhancement in cardiac magnetic resonance in patients with systemic sclerosis.
    Sano M; Satoh H; Suwa K; Nobuhara M; Saitoh T; Saotome M; Urushida T; Katoh H; Shimoyama K; Suzuki D; Ogawa N; Takehara Y; Sakahara H; Hayashi H
    Heart Vessels; 2015 Nov; 30(6):779-88. PubMed ID: 24996373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hybrid Cardiac Magnetic Resonance/Fluorodeoxyglucose Positron Emission Tomography to Differentiate Active From Chronic Cardiac Sarcoidosis.
    Greulich S; Gatidis S; Gräni C; Blankstein R; Glatthaar A; Mezger K; Müller KAL; Castor T; Mahrholdt H; Häntschel M; Hetzel J; Dittmann H; Nikolaou K; Gawaz M; la Fougère C; Krumm P
    JACC Cardiovasc Imaging; 2022 Mar; 15(3):445-456. PubMed ID: 34656480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T(1) mapping for the diagnosis of acute myocarditis using CMR: comparison to T2-weighted and late gadolinium enhanced imaging.
    Ferreira VM; Piechnik SK; Dall'Armellina E; Karamitsos TD; Francis JM; Ntusi N; Holloway C; Choudhury RP; Kardos A; Robson MD; Friedrich MG; Neubauer S
    JACC Cardiovasc Imaging; 2013 Oct; 6(10):1048-1058. PubMed ID: 24011774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Late gadolinium enhancement identified with cardiac magnetic resonance imaging in sarcoidosis patients is associated with long-term ventricular arrhythmia and sudden cardiac death.
    Nadel J; Lancefield T; Voskoboinik A; Taylor AJ
    Eur Heart J Cardiovasc Imaging; 2015 Jun; 16(6):634-41. PubMed ID: 25617029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. QRS-based assessment of myocardial damage and adverse events associated with cardiac sarcoidosis.
    Sobue Y; Harada M; Koshikawa M; Ichikawa T; Yamamoto M; Okuda K; Kato Y; Sarai M; Watanabe E; Ozaki Y
    Heart Rhythm; 2015 Dec; 12(12):2499-507. PubMed ID: 26362576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detecting cardiac involvement with magnetic resonance in patients with active eosinophilic granulomatosis with polyangiitis.
    Yune S; Choi DC; Lee BJ; Lee JY; Jeon ES; Kim SM; Choe YH
    Int J Cardiovasc Imaging; 2016 Jun; 32 Suppl 1():155-62. PubMed ID: 26831057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does stress perfusion imaging improve the diagnostic accuracy of late gadolinium enhanced cardiac magnetic resonance for establishing the etiology of heart failure?
    Gulsin GS; Shetye A; Khoo J; Swarbrick DJ; Levelt E; Lai FY; Squire IB; Arnold JR; McCann GP
    BMC Cardiovasc Disord; 2017 Apr; 17(1):98. PubMed ID: 28390413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High mass (>18g) of late gadolinium enhancement on CMR imaging is associated with major cardiac events on long-term outcome in patients with biopsy-proven extracardiac sarcoidosis.
    Agoston-Coldea L; Kouaho S; Sacre K; Dossier A; Escoubet B; Chillon S; Laissy JP; Rouzet F; Kutty S; Extramiana F; Leenhardt A; Borie R; Crestani B; Ou P
    Int J Cardiol; 2016 Nov; 222():950-956. PubMed ID: 27526366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.